
Andrew McKenzie’s group in the LMB’s PNAC Division have shown for the first time that a new immune cell type, the nuocyte, can orchestrate the initiation of allergic asthma in an experimental model. Nuocytes were shown to cause airway hyperactivity – a key feature of human asthma.